Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 30,017 | 10,971 | 7,179 | 9,005 | 3,318 |
| Gross Profit | 30,017 | 10,971 | 7,179 | 9,005 | 3,318 |
| Operating Expenses | 52,774 | 51,292 | 49,380 | 51,140 | 41,050 |
| Operating Income | -22,757 | -40,321 | -42,201 | -42,135 | -37,732 |
| Other Income | -10,094 | -6,330 | -1,735 | -80 | 424 |
| Pre-tax Income | -32,851 | -46,651 | -43,936 | -42,215 | -37,308 |
| Income Tax | N/A | 9 | N/A | N/A | N/A |
| Net Income Continuous | -32,851 | -46,660 | -43,936 | -42,211 | -37,308 |
| Net Income | $-32,851 | $-46,660 | $-43,936 | $-42,211 | $-37,308 |
| EPS Basic Total Ops | -1.14 | -1.71 | -1.64 | -1.59 | -1.41 |
| EPS Basic Continuous Ops | -1.14 | -1.71 | -1.64 | -1.59 | -1.41 |
| EPS Diluted Total Ops | -1.14 | -1.71 | -1.64 | -1.59 | -1.41 |
| EPS Diluted Continuous Ops | -1.14 | -1.71 | -1.64 | -1.59 | -1.41 |
| EPS Diluted Before Non-Recurring Items | -1.14 | -1.71 | -1.64 | -1.59 | -1.41 |
| EBITDA(a) | $-24,727 | $-42,203 | $-44,564 | $-44,685 | $-40,133 |